Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Global Roundtable Corporation GRCU OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Global Roundtable Corporation (GRCU) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $1M, +712.6%/yr average growth. Net income is $243,229 (loss), growing at +14.7%/yr. Net profit margin is -18.7% (negative). Gross margin is 36.8% (+30.5 pp trend).

Balance sheet: total debt is $373,353 against $656,117 equity (Debt-to-Equity (D/E) ratio 0.57, moderate). Current ratio is 0.84 (tight liquidity). Debt-to-assets is 18.3%. Total assets: $2M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 90/100 (Pass), Past 25/100 (Fail), Health 17/100 (Fail), Moat 36/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

GRCU SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 90/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 36/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — GRCU

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
90/100
GRCU: +712.6%/yr revenue is, +14.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
GRCU: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
17/100
Balance sheet GRCU: Debt-to-Equity (D/E) ratio 0.57 (moderate), Current ratio is 0.84 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
36/100
GRCU: Gross margin is 36.8% (+30.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 36/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
GRCU: Net profit margin is -18.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.00005-0.0002
Volume100K
Avg Volume (30D)732.97K
Market Cap$522.63K
Beta (1Y)10.00
Share Statistics
Shares Outstanding$6.98B
IPO Date2005-02-21
Employees20
CEORich Thomas
Financial Highlights & Ratios
Revenue (TTM)$1.3M
Gross Profit$478.63K
EBITDA$-186.45K
Net Income$-243.23K
Operating Income$-226.28K
Total Cash$362.96K
Total Debt$373.35K
Net Debt$10.39K
Total Assets$2.03M
Price / Sales (P/S)0.4
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS3930072083

Price Chart

Track all markets on TradingView
GRCU
Global Roundtable Corporation ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

CHNC
CHNC
China Infrastructure Construction Corp.
$0.00
+14.94%
 CNNA
CNNA
Cann American Corp.
$0.00
+0.00%
 HBRM
HBRM
Herborium Group, Inc.
$0.00
+9,900.00%
 NNRX
NNRX
Nutranomics, Inc.
$0.00
+0.00%
 INQD
INQD
Indoor Harvest Corp
$0.00
+100.00%
 GXXY
GXXY
Galexxy Holdings, Inc.
$0.00
+0.00%
 GRPS
GRPS
Gold River Productions, Inc.
$0.00
+0.00%
 RMRK
RMRK
Rimrock Gold Corp.
$0.00
+20.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message